Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this session, "An Eagle's View - Evidence-based discussion on Iron Deficiency Anemia." This discussion will provide a high-level, evidence-based overview of Iron Deficiency Anemia (IDA), the most common nutritional deficiency worldwide. Despite its prevalence, IDA is often underdiagnosed and undertreated, leading to significant health consequences. This session will offer a fresh perspective on the latest clinical data, moving beyond traditional approaches to focus on effective and patient-centered management strategies.
The discussion will explore the evidence supporting different therapeutic options, including oral iron supplementation and intravenous iron infusions. We'll delve into the specific patient populations that benefit most from each approach, such as those with intolerance to oral supplements, pregnant women, or patients with chronic conditions. Recent research has highlighted the improved safety and efficacy of modern intravenous iron formulations, making them a more viable and often preferred option for rapid iron replenishment and symptom relief. We will also address the challenges in diagnosis, particularly when inflammatory markers are elevated.
Therefore, get an overall knowledge of the evidence-based best practices in the diagnosis and treatment of iron deficiency anemia. Listen to the webinar, absorb the shared knowledge, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Do I qualify for a cancer clinical trial?
2.
Short-course radiation matches standard therapy for endometrial cancer
3.
One-third of childhood cancer survivors experience significant fear that it could come back, study reveals
4.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
5.
Eight Doctors Killed in Brazil's Horrifying Plane Crash
1.
Understanding Epidural Hematoma: Symptoms, Causes and Treatment
2.
Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma
3.
Precision Erythropoietic Modeling for Hematologic Disorders
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
5.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation